Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Most patients improved with oral contraceptives, but some needed additional treatment.

Combined finasteride and anastrozole therapy effectively treats BPH, influenced by hormone imbalances and genetics.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

The combined Myo-inositol and D-chiro-inositol treatment improved weight, hormone levels, and skin conditions in women with PCOS.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Gender-affirming hormone therapy may increase heart disease risk in transgender individuals.

Women have unique stroke risks due to hormones, contraceptives, pregnancy, and menopause.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Lower testosterone levels may increase heart failure risk in older men.

Adding estrogen increased bone mass in a transsexual man undergoing hormone therapy.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Following national healthy eating guidelines can help reduce risks from gender-affirming hormone therapy.

Creating evidence-based guidelines for gender incongruence is difficult due to the personalized nature of transgender medicine.

Sex and stress steroids quickly change brain cell structures in the hippocampus.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Men's fertility and sexual health decline with age, with reduced testosterone and virility, and many lose fertility by their eighties.

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.